CO 127501
Latest Information Update: 23 Dec 2002
Price :
$50 *
At a glance
- Originator Purdue Pharma
- Class Anxiolytics; Hypnosedatives
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Insomnia
Most Recent Events
- 23 Dec 2002 Discontinued - Preclinical for Insomnia in USA (unspecified route)
- 17 Jan 2000 New profile
- 17 Jan 2000 Preclinical development for Insomnia in USA (Unknown route)